The scope of this focused update is limited to addressing recommendations on duration of
dual antiplatelet therapy (DAPT)(aspirin plus a P2Y12 inhibitor) in patients with coronary …

Background—Epidemiology and consequences of surgery in patients with coronary stents
are not clearly defined, as well as the impact of different stent types in relationship with …

Background The perioperative safety profile of clopidogrel, a potent antiplatelet agent used
in the management of cardiovascular disease, is unknown, and there are no evidence …

As the number of percutaneous coronary interventions increase annually, patients with
intracoronary stents (ICS) who present for noncardiac surgery (NCS) are also on the rise …

Surgery may necessitate interruption of dual antiplatelet therapy (DAPT) within the first year
after coronary drug-eluting stent (DES) implantation. We conducted a population-based …

Intravenous administration of a short acting glycoprotein IIb/IIIa inhibitor has been proposed
as a bridge to surgery in patients on dual antiplatelet treatment, but data in comparison with …

Background Platelet inhibition is mandatory therapy after percutaneous coronary
intervention (PCI). Withdrawal of oral antiplatelet agents has been linked to increased …

The scope of this focused update is limited to addressing recommendations on duration of
dual antiplatelet therapy (DAPT)(aspirin plus a P2Y12 inhibitor) in patients with coronary …

髋, 膝关节置换术患者合并心血管疾病时是发生动静脉血栓栓塞的高危因素,
部分合并心血管疾病患者已用华法林, 术中出血风险增加. 为提高合并心血管疾病的髋 …

Physicians commonly encounter patients undergoing noncardiac surgery who have
previously received a coronary artery stent. 1 Several large observational studies have …